Here we are, almost Monday January 24, 2011. After the market close, 1PM, PT, the very important 4th quarter will be announced. This moment is very pivotal as it will reveal if the new Prolia/Xgeva is selling at significant figures. We really have nothing else to look at but, Amgen shows its worry by announcing new prices for our drugs. One analyst said it is being done to offset the lagging sales. They have tons of money but not a cent (dividend) for the shareholder. Shall we form a prayer circle? That might help.
If the earnings, and denosumab sales are not what the street hopes for, two things should happen, share price descends and overhead reduction announcements will be made. The sale of the Fremont facility is a start.
Don't worry about the "field force", it's the analysts that set the pace along with the other money managers. The street consensus is $1.06 to $1.11 EPS. No one knows the deno sales figures. That will be announced this Monday.
Fuckin r*****/dimwit J lenzo-ED of BHBU market access and right hand of HT is OUT now (replaced with SS-right hand of Rick R). Its a pretty clear sign for next days to come for Kirstin D and finally Helen T and over all dmab sales. Maybe new leadership will change the direction and morale somewhat!!!!!!!!!!!
Today (1-24-11) after the market close (1 PM PT), we get the whole picture where we are going, such as denosumab sales and the hoped for DIVIDEND. If we get positive comments on both, the shares will certainly rise. Also, look for comments about overhead adjustments.
